background coal norm involve pathogenesis act exacerb idiopathic pulmonary fibrosis aef administer recombin human soluble thrombomodulin htm antiinflammatori anticoagul active improv outcome respiratory function patient distress syndrome therefore conduct prospect clinic studi examine effect marker method register protocol satisfy include criterion treat daily kg day steroid put therapy concomit immunosuppress polymyxin bimmobil fiber column treatment prohibit sample size subject primary outcome improv profit ratio week init secondary chang dimer level time day survive rate without into data compare history treat comparison group include result mean n significantly improv one today analysis variant p tend decrease signifies higher differ post hoc show overall longer logan test concur pl function expect improv patient use combine therapy trial relist universe host medic inform network registry uminctr actor min 